Does DALBAVANCIN Cause Infusion site extravasation? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Infusion site extravasation have been filed in association with DALBAVANCIN (DALBAVANCIN HYDROCHLORIDE). This represents 1.9% of all adverse event reports for DALBAVANCIN.
21
Reports of Infusion site extravasation with DALBAVANCIN
1.9%
of all DALBAVANCIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Infusion site extravasation From DALBAVANCIN?
Of the 21 reports, 3 (14.3%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALBAVANCIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does DALBAVANCIN Cause?
Off label use (192)
Rash (99)
Pruritus (64)
Dyspnoea (62)
Back pain (61)
Erythema (56)
Vomiting (54)
Hypersensitivity (49)
Nausea (45)
Drug ineffective (44)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which DALBAVANCIN Alternatives Have Lower Infusion site extravasation Risk?
DALBAVANCIN vs DALFAMPRIDINE
DALBAVANCIN vs DALTEPARIN
DALBAVANCIN vs DAMOCTOCOG ALFA PEGOL
DALBAVANCIN vs DANAPAROID
DALBAVANCIN vs DANAZOL